Bridged α-helix mimetic small molecules

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Drug Discovery

Background:

• Alpha-helix mimetics are crucial in drug discovery for targeting protein-protein interactions.
• Conformational flexibility can limit the binding affinity and specificity of small molecule mimetics.
• Developing conformationally restricted mimetics is key to enhancing drug-like properties.

Purpose of the Study:

• To develop a novel strategy for generating conformationally restricted alpha-helix mimetic small molecules.
• To investigate the impact of covalent bridges on the conformational stability of alpha-helix mimetics.
• To evaluate the binding affinity and specificity of these novel mimetics to their target proteins.

Main Methods:

• Design and synthesis of alpha-helix mimetics incorporating covalent bridges.
• Structural analysis to confirm conformational restriction.
• Biochemical assays to measure binding affinity and specificity against target proteins.

Main Results:

• Successful generation of conformationally restricted alpha-helix mimetics via covalent bridging.
• Demonstrated enhanced binding affinity to the target protein compared to non-bridged counterparts.
• Observed improved specificity due to restricted conformation and additional bridge-protein interactions.

Conclusions:

• Covalent bridging is an effective strategy to achieve conformational restriction in alpha-helix mimetics.
• Restricted conformation and additional interactions significantly enhance binding affinity and specificity.
• These findings pave the way for developing more potent and selective therapeutics based on alpha-helix mimetics.